CANCER'S CAUSE, CANCER'S CURE (36 page)

110. - M. BELJANSKI, S.K. DUTTA, Differential synthesis and replication of DNA in the Neurospora crassa slime mutant versus normal cells: Role of carcinogens È. Oncology, 44, 1987, pp. 327-330.

111. - S.K. DUTTA, M. BELJANSKI, Particular RNA primer from growth medium differentially stimulates
in vitro
DNA synthesis and in vivo cell growth of Neurospora crassa and its slime mutant È. Current Genetics, 12, 1987, pp. 283-289.

112. - M. BELJANSKI, L.C. NIU, M.S. BELJANSKI, S. YAN, M.C. NIU, Iron stimulated RNA-dependent DNA polymerase Activity from goldfish eggs È. Cellular and Molecular Biology, 34, 1988, pp. 17-25.

113. - L. LE GOFF, M. WICKER, M. BELJANSKI, Reversible biophysical changes of DNAs from
in vitro
culturel non-tumour cells È. Med. Sci. Res., 16, 1988, pp. 359-360.

114. - M. STROUN, P. ANKER, P. MAURICE, J. LYAUTEY, C. LEDERREY, M. BELJANSKI, Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients È. Oncology, 16, 1989, pp. 318-322.

115. - M. BELJANSKI, M.S. BELJANSKI, M. GRANDI Resultati preliminari dell’impiego di tre alcaloidi nel carcinoma prostatico È. In Tumori, Instituo Nationale per le studio ed la cura dei tumori (ed. Lambrosiana), Vol. 75, suppl. 4, 1989.

116. - M. BELJANSKI, é Cancer therapy: A New Approach È. Deutsche Zeitschrift für Onkologie 5, 22, 1990, pp. 145-152.

117. - M. BELJANSKI, Cancer et Sida. Nouvelles approches thérapeutiques È. 5ﾏmes Entretiens Internationaux de Monaco, 21-24 novembre 1990 (Ed. du Rocher), pp. 25-34.

118. - D. DONADIO, R. LORHO, J.E. CAUSSE, T. NAWROCKI, M. BELJANSKI, RNA fragments (RLB) and Tolerance of Cytostatic Treatments in Hematology: A Preliminary Study about Two Non-Hodgkin Malignant Lymphoma Cases È. Deutsche Zeitschrift für Onkologie, 23, 2, 1991, pp. 33-35.

119. - M. BELJANSKI, Reverse Transcriptases in Bacteria: Small RNAs as Genetic Vectors and Biological Modulators È. Brazil. J. Genetics, 14, 4, 1991, pp. 873-896.

120. - M. BELJANSKI, Radioprotection of Irradiated Mice - Mechanisms and Synergistic Action of WR-2721 and R.L.B. È. Deutsche Zeitschrift für Onkologie, 23, 6, 1991, pp. 155-159.

121. - M. BELJANSKI, Overview: BLRs as Inducers of in vivo Leucocyte and Platelet Genesis È. Deutsche Zeitschrift für Onkologie, 24, 2, 1992, pp. 45-45.

122. - M. BELJANSKI, A New Approach to Cancer Therapy È. Proceedings of the international seminar: Traditional Medicine: A Challenge of the 21st Century, 7-9 Nov. 1992, Calcutta (Ed. in chief Biswapati Mukherjee).

123. - M. BELJANSKI, S. CROCHET, M.S. BELJANSKI, PB100: A Potent and Selective Inhibitor of Human BCNU Resistant Glioblastoma Cell Multiplication È. Anticancer Research, vol. 13, n¡6A, Nov. Dec. 1993, pp. 2301-2308.

124. - M. BELJANSKI, S. CROCHET, Differential effects of ferritin, calcium, zinc and gallic acid on
in vitro
proliferation of human glioblastoma cells and normal astrocytes È. J. Lab. Clin. Med. 123:547- 555, 1994.

125. - M. BELJANSKI, S. CROCHET, The selective anticancer agent PB-100 inhibits interleukin-6 induced enhancement of glioblastoma cell proliferation in vitro È. International Journal of Oncology, 5:873-879, 1994.

126. - M. BELJANSKI, S. CROCHET, Selective inhibitor (PB-100) of human glioblastoma cell multiplication È. Journal of Neuro-Oncology, Vol. 21, N¡1, p. 62, 1994.

127. - J.E. CAUSSE, T. NAWROCKI, M. BELJANSKI, Human Skin Fibrosis Rnase Search for a Biological Inhibitor-Regulator È. Deutsche Zeitschrift für Onkologie, 26, 5, 1994, pp. 137-139.

128. - M. BELJANSKI, S. CROCHET, The anticancer agent PB100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes È. International Journal of Oncology 7:81-85, 1995.

129. - M. BELJANSKI, Novel selective non-toxic anticancer and antiviral agents È. International Journal of Oncology Vol. 7. supplement, p. 983, October 1995.

130. - M. BELJANSKI, S. CROCHET, The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts È. International Journal of Oncology 8:1143-1148, 1996.

131. - M. BELJANSKI, S. CROCHET, Mitogenic effect of several interleukins, neuromediators and hormones on human glioblastoma cells, and its inhibition by the selective anticancer agent PB-100 È. Deutsche Zeitschrift für Onkologie, 28, 1, 1996, pp. 14-2.

132. - M. BELJANSKI, De novo synthesis of DNA - like molecules by polyaudeotide phosphorylase in vitro È. J. Mol. Evol. 1996, 42:493-499.

133. - M. BELJANSKI, The anticancer agent PB-100, selectively active on malignant cells, inhibits multiplication of sixteen malignant cell lines, even multidrug resistant. È Genetics and Molecular Biology, 23, 1, 29-33 (2000).

About the Author

D
r. Morton Walker, D.P.M., is a professional medical journalist who has authored 92 published books, 14 of which are bestsellers, and over 2000 clinical journal and magazine articles about holistic medicine, orthomolecular nutrition, and other alternative methods of healing. Named “The World’s Leading Medical Journalist Specializing In Holistic Medicine” by the American Cancer Control Society, Dr. Walker lives and conducts his medical journalism research in Florida. He is the recipient of 23 medical journalism awards for his breakthrough works in many areas including longevity, chelation therapies, and cancer. Dr. Walker’s most recent works, including The Gerson Therepies coauthored with Charlotte Gerson, The Yeast Syndrome: How to Help Your Doctor Identify & Treat the Real Cause of Your Yeast-Related Illness coauthored with John P. Trowbridge, and Olive Leaf Extract, have all sold over one million copies.

For more information on Dr. Morton Walker and his work, please visit
www.DrMortonWalker.com
.